Press Releases
Hundreds of community members, elected officials, higher education and transportation officials celebrated the new stations across four ceremonies in June 2025
MONROVIA, Calif., June 21, 2025 /PRNewswire/ -- This month, the Foothill Gold Line Construction Authority (Construction Authority) held a series of station dedication ceremonies in the corridor cities along the 9-mile, four-station Foothill Gold Line light rail project from Glendora to Pomona. Attendance was... (continue reading...)
New York, New York--(Newsfile Corp. - June 21, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Krispy Kreme, Inc. (NASDAQ: DNUT) between February 25, 2025 and May 7, 2025, both dates inclusive (the "Class Period"), of the important July 15, 2025 lead plaintiff deadline.
SO WHAT: If you purchased Krispy Kreme securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees... (continue reading...)
Treatment with apelin receptor agonist enhanced glycemic control and demonstrated cardioprotective effects, with additive benefits observed in combination with incretin therapy
Data support development of next-generation APJ agonists for obesity and key comorbidities
EMERYVILLE, Calif., June 21, 2025 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (Nasdaq: BIOA) (“BioAge”, “the Company”), a clinical-stage biotechnology company developing therapeutic product candidates... (continue reading...)
New York, New York--(Newsfile Corp. - June 21, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) between February 27, 2025 and May 26, 2025, both dates inclusive (the "Class Period"), of the important August 11, 2025 lead plaintiff deadline.
SO WHAT: If you purchased Rocket Pharmaceuticals securities during the Class Period you may be entitled to compensation without payment of... (continue reading...)
New York, New York--(Newsfile Corp. - June 21, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Elevance Health, Inc. (NYSE: ELV) between April 18, 2024 and October 16, 2024, both dates inclusive (the "Class Period"), of the important July 11, 2025 lead plaintiff deadline.
SO WHAT: If you purchased Elevance common stock during the Class Period you may be entitled to compensation without payment of any out of pocket... (continue reading...)
More Press Releases
View Older Stories-
QuantaNorth.com reviews precious metals as a hedge for Canadian traders (by Paul Krause)
-
QuantaNorth.com reviews crypto volatility with smart risk management (by Martin Heinz)
-
Celebrity Stylist Axel Rojas Opens Hair Salon in Dallas
-
CODI DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Compass Diversified Holdings Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - CODI
-
Can’t Wait for XRP to Hit $10? PFMCrypto Launches 1-Day Cloud Mining Contract With $10 Free Bonus
-
CIVI DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Civitas Resources, Inc. Investors to Secure Counsel Before Important July 1 Deadline in Securities Class Action - CIVI
-
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Fortrea Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FTRE
-
NSSC DEADLINE ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages NAPCO Security Technologies, Inc. Investors to Secure Counsel Before Important June 24 Deadline in Securities Class Action - NSSC
-
ZA Miner Launches Free Cloud Mining App Amid Rising Crypto Adoption in 2025
-
XRP Struggles to Break $3 Barrier, While PFMCrypto Launches Innovative XRP Cloud Mining Contracts to Widespread Interest
-
XRP News: Vaultro Finance Presale on XRP Is Set to End in 7 Days, Already Sold Out 72% of Its Allocation — Join $VLT Presale Now
-
Semaglutide Increases Walking Capacity in Patients with Peripheral Artery Disease and Type 2 Diabetes
-
Trump, Munir exchange praises as Pakistan rises as regional stabilizer: IRS Analysis
-
Canadian North Resources Announces Results of 2025 Annual and Special Meeting of Shareholders
-
Abvance Therapeutics Announces Presentation of Human Clinical Data at the 85th Scientific Sessions of the American Diabetes Association
-
J. David Tax Law Offers Expert Help for IRS and State Tax Debts in Houston
-
TEAMSTERS NURSES AT COREWELL RALLY AGAINST EMPLOYERS' ATTACKS
-
PU Prime and Argentina Football Association Celebrate Official Signing Ceremony in Madrid
-
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages GeneDx Holdings Corp. Investors to Inquire About Securities Class Action Investigation - WGS
-
Debt Consolidation Loan for Poor Credit Score: Radcred Instant Funding Solution with No Credit Check & Same-Day Loan
-
Acki Nacki Partners With Top Casters For Live Popit Games Final
-
FHI Expands Mission Beyond Staffing to Deliver Full-Spectrum Supply Chain Solutions
-
Winners of the 27th Shanghai International Film Festival Golden Goblet Awards Revealed
-
Kaanch Network Presale Positions Project Among Top Altcoins and Best Crypto Opportunities of 2025
-
OCUFA Challenges Ontario Government's Narrative on Postsecondary Funding Crisis, Welcomes Review with Call for Meaningful Faculty Consultation
-
LPRO INVESTOR NOTICE: Open Lending Corporation Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit
-
The Finale Concert of The Treasured Voice Season 6 Unites Audience from Singapore, Malaysia, Indonesia and More to Boost Chinese-language Music Going Global
-
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elevance Health
-
BexBack Launches $50 Welcome Bonus and 100% Deposit Match to Empower Crypto Traders with 100x Leverage
-
ROSEN, REGARDED INVESTOR COUNSEL, Encourages GoHealth, Inc. Investors to Inquire About Securities Class Action Investigation - GOCO
-
Martini Market Presale Surpasses 40% of Softcap Within 24 Hours of Launch on XRP Ledger
-
Wilson Blanchard Management Raises $169,000 at 2025 WB CondoCon in Support of Associa Cares Canada
-
Wai Lana Re-Releases "Namaste" Music Video for 10th Anniversary of International Yoga Day
-
XRP News: Vaultro Finance Presale on XRP Sells Over 70% of Allocation – Only 30% Now Remaining for Early Investors to Participate
-
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Semler Scientific, Inc. Investors to Inquire About Securities Class Action Investigation - SMLR
-
AIXA Miner Unveils New Free Cloud Mining Platform Aligned with 2025 Green Tech and Smart Mining Goals
-
QuantaNorth.com reviews how climate policy shifts are affecting commodity prices (by Scott Weber)
-
QuantaNorth.com reviews forex trading strategies for a stronger Canadian dollar environment (by Robert White)
-
Government of Pakistan Recommends President Donald J. Trump for 2026 Nobel Peace Prize
-
WST DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - WST
-
‘Reputation House’ Becomes the Only Dubai-Based Winner at the 2025 American Business Awards
-
John Binks Advances Federal Tech Innovation and AI Literacy in Leadership Role at Titan Technologies
-
Lilly's oral GLP-1, orforglipron, showed compelling efficacy and a safety profile consistent with injectable GLP-1 medicines, in complete Phase 3 results published in The New England Journal of Medici
-
Bible For Beginners: Themes & Historical Context Practical Guide Released
-
MetaVia Presents Pre-Clinical Data on DA-1241 Demonstrating Additive Hepatoprotective Effects in Combination With Efruxifermin at the ADA's 85th Scientific Session
-
Solytics Partners Appoints Financial Crime Compliance Expert Sunil Kavishwar to Advisory Board to Strengthen AML Efforts in the GCC
-
New data demonstrates robust efficacy of Vyepti® (eptinezumab) in otherwise difficult-to-treat patients with severe migraine
-
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services
-
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Organon
-
New data from phase III trial confirms efficacy of Vyepti® (eptinezumab) in Asian population with chronic migraine
